4-(3,4-二氯苯基)-1,2,3,4-四氢-N-甲基-1-萘胺盐酸盐结构式
|
常用名 | 4-(3,4-二氯苯基)-1,2,3,4-四氢-N-甲基-1-萘胺盐酸盐 | 英文名 | cis-N-Methyl-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthalenamine hydrochloride |
|---|---|---|---|---|
| CAS号 | 79617-89-3 | 分子量 | 342.690 | |
| 密度 | N/A | 沸点 | 443.8ºC at 760 mmHg | |
| 分子式 | C17H18Cl3N | 熔点 | 275-277ºC | |
| MSDS | N/A | 闪点 | 222.2ºC | |
| 符号 |
GHS07 |
信号词 | Warning |
用途舍曲林中间体 |
| 中文名 | 舍曲林碱 |
|---|---|
| 英文名 | cis-N-Methyl-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthalenamine hydrochloride |
| 中文别名 | 4-(3,4-二氯苯基)-1,2,3,4-四氢-N-甲基-1-萘胺盐酸盐 |
| 英文别名 | 更多 |
| 沸点 | 443.8ºC at 760 mmHg |
|---|---|
| 熔点 | 275-277ºC |
| 分子式 | C17H18Cl3N |
| 分子量 | 342.690 |
| 闪点 | 222.2ºC |
| 精确质量 | 341.050476 |
| PSA | 12.03000 |
| LogP | 6.37250 |
|
~78%
4-(3,4-二氯苯基)-1,... 79617-89-3 |
| 文献：UNICHEM LABORATORIES LIMITED Patent: WO2007/119247 A2, 2007 ; Location in patent: Page/Page column 23 ; |
|
~%
4-(3,4-二氯苯基)-1,... 79617-89-3 |
| 文献：WO2007/124920 A1, ; Page/Page column 14-15 ; |
|
~%
4-(3,4-二氯苯基)-1,... 79617-89-3 |
| 文献：US2006/14838 A1, ; Page/Page column 2-3 ; |
| 上游产品 2 | |
|---|---|
| 下游产品 0 | |
|
Development and validation of LC-MSMS assay for the determination of the prodrug dabigatran etexilate and its active metabolites in human plasma.
J. Chromatogr. B. Analyt. Technol. Biomed. Life Sci. 989 , 37-45, (2015) Dabigatran etexilate (DABE) is a low-molecular-weight prodrug that is converted after oral administration to dabigatran (DAB)-a directly acting oral anticoagulant. In this study, an LC-MSMS assay was ... |
|
|
Multifaceted interaction of the traditional Chinese medicinal herb Schisandra chinensis with cytochrome P450-mediated drug metabolism in rats.
J. Ethnopharmacol. 155(3) , 1473-82, (2014) Schisandra chinensis (SC), officially listed as a sedative and tonic in the Chinese Pharmacopoeia, has been used as a common component in various prescriptions in Traditional Chinese Medicine (TCM) an... |
|
|
Cannabinoids prevent the effects of a footshock followed by situational reminders on emotional processing.
Neuropsychopharmacology 39(12) , 2709-22, (2014) Posttraumatic stress disorder (PTSD) can develop following exposure to a traumatic event. Hence, what we do in the first few hours after trauma exposure may alter the trajectory of PTSD. We examined w... |
| cis-N-methyl-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-N-methyl-1-naphthalenamine hydrochloride |
| [4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydronaphthalen-1-yl]methylamine hydrochloride |
| 4-(3,4-Dichlorophenyl)-N-methyl-1,2,3,4-tetrahydro-1-naphthalenamine hydrochloride (1:1) |
| cis-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-N-methyl-1-naphthaleneamine hydrochloride |
| 1-Naphthalenamine, 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-N-methyl-, hydrochloride (1:1) |
| 4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydronaphthalen-1-amine hydrochloride |
| cis(1S,1R)-N-methyl-4-(3,4-dichlorophenyl)-1,2,3,4-terahydro-1-(2H)-napthalenamine hydrochloride |
| (+/-)-sertraline hydrochloride |
| 4-(3,4-Dichlorophenyl)-N-methyl-1,2,3,4-tetrahydronaphthalen-1-amine hydrochloride (1:1) |
| 4-(3,4-DICHLOROPHENYL)-1,2,3,4-TETRAHYDRO-N-METHYL-1-NAPHTHALENAMINEHYDROCHLORIDE |
| Sertraline Hydrochloride Racemic Mixture (25 mg) (1:1 mixture of (1S,4S) and (1R,4R)-4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydro-1-naphthylamine hydrochloride) |
